Palantir Technologies smashed through a major milestone Tuesday, topping a $300 billion market cap for the first time ever ...

Palantir's stock is seeing a boost from reports that the U.S. and Saudi Arabian governments have reached a new deal that ...

In the first quarter of 2025, Palantir reported revenues of $884 million, a 39% year-over-year increase. The U.S. commercial ...

While Cisco's valuation never fully recovered, the company's current market cap of $236 billion is still far greater than it ...

Palantir stock tumbled Tuesday as investors scrutinized the company's high valuation and declining sales to international ...

Palantir shares have advanced 550% since January 2024, which makes it the best performing stock in the S&P 500 and the second ...

Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Palantir stock has been on a tear in 2025, rising more than 40% even after Tuesday's big drop. Analysts have expressed ...

Palantir upped full-year guidance and delivered an above-consensus guide for Q2 FY 2025, thereby completing a triple play.

Five Wall Street banks have revised their Palantir stock price targets — and most see downside in the cards for the data ...

Palantir shares tumbled Tuesday despite the company's strong results and outlook, as investors may have expected more from ...